Using Medicare administrative data to conduct postmarketing surveillance of follow-on biologics: issues and opportunities.
DiMartino
Lisa D
LD
Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA.
Curtis
Lesley H
LH
Williams
Roger L
RL
Abernethy
Darrell R
DR
Schulman
Kevin A
KA
D001688:Biological Products / Q000009:adverse effects* / Q000627:therapeutic use; D017277:Drug Approval / Q000379:methods*; D049228:Healthcare Common Procedure Coding System; D006801:Humans; D007344:Insurance Claim Reporting; D038801:International Classification of Diseases; D017387:Investigational New Drug Application / Q000379:methods*; D006278:Medicare; D011358:Product Surveillance, Postmarketing / Q000379:methods*; D013810:Therapeutic Equivalency; D014481:United States
D001688:Biological Products